EHCEncompass Health Corporation
121.60USD-0.12%Mkt Cap: 12.01B $P/E: 20.29

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis …

Key Statistics

Company
Market Cap12.01B $
Enterprise Value15.53B $
Revenue (TTM)6.21B $
Gross Profit5.68B $
Net Income (TTM)566.20M $
Revenue/Share62.25 USD
Last Price121.60 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees29.7K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN
Valuation
P/E (Trailing)20.29
P/E (Forward)18.11
PEG0.41
EV/EBITDA10.61
EV/Revenue2.50
P/S1.92
P/B4.60
EPS (TTM)5.95
EPS (Forward)6.68
52W Range
92.7782% of range127.99
52W High127.99 USD
52W Low92.77 USD
Profitability
Gross Margin95.71%
Oper. Margin18.05%
EBITDA Margin23.58%
Profit Margin9.54%
ROE23.22%
ROA7.99%
Growth
Revenue Growth9.60%
Earnings Growth10.80%
Cash Flow & Leverage
Operating CF1.18B $
CapEx (TTM)736.40M $
FCF Margin3.70%
FCF Yield1.91%
Net Debt2.73B $
Net Debt/EBITDA1.87
Balance Sheet
Debt/Equity1.11
Current Ratio1.19
Quick Ratio0.91
Book Value/Sh26.29 USD
Cash/Share1.092 USD
Dividends
Fwd Div Rate0.8400 USD
Trail. Div Rate0.7600 USD
Div. Yield0.69%
5Y Avg Yield1.09%
Payout Ratio12.69%
Ex-Div DateOct 1, 2026
Pay DateOct 15, 2026
Splits
Last Split1257:1000
Split DateJul 1, 2022
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)148.17 USD
Upside (mean)+21.8%
Target Range140.00 USD155.00 USD
$140.00+21.8% to mean$155.00
# Analysts12
Ownership
Shares Out.98.65M
Float97.65M
Insiders0.87%
Institutions100.37%
Short Interest
Short Ratio4.1d
Short % Float4.18%
Short % Out.3.70%
Shares Short3.65M
Short (prev mo.)3.10M
Technical
SMA 50110.71 (+9.8%)
SMA 200106.90 (+13.8%)
Beta0.60
S&P 52W Chg18.16%
Avg Vol (30d)741.80K
Avg Vol (10d)948.58K
Technical Indicators
RSI (14)62.7
MACD3.9391
MACD Signal3.7902
MACD Hist.+0.1489
BB Upper130.10 USD
BB Middle117.57 USD
BB Lower105.04 USD
BB Width21.32%
ATR (14)3.286 USD
Vol Ratio (20d)0.89x